Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Cronos Group Inc TSX: CRON-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 8.91
Day High 9.29
Open:9.11
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Hold

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies
- GlobeNewswire - Thu Jul 29, 6:15AM CDT
GlobeNewswire - CMTX
Thu Jul 29, 6:15AM CDT
SOURZ by Spinach(TM) gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting dual flavors and dual colors
CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025
- PR Newswire - PRF - Tue Jul 27, 7:45AM CDT
PR Newswire - PRF - CMTX
Tue Jul 27, 7:45AM CDT
/PRNewswire/ -- The CBD market has achieved steady growth curve even during the pandemic. CBD or cannabidiol is a natural substance derived from cannabis, found in both marijuana and the non-psychoactive hemp plant. CBD is a non-psychoactive chemical compound and may alleviate things such as anxiety and pain, which is why it is used to create wellness products, such as oils, edibles and functional beverages. The pandemic caused a shift in CBD sales to online channels. While this shift ensured that CBD products remained accessible to consumers, it did not fully compensate for the loss of education and brand awareness available at some retail stores. A survey by Brightfield Group from found that 45% of CBD consumers and 54% of millennial consumers shifted to purchasing CBD online due to the coronavirus crisis. Charlotte's Web reported that online sales grew 27% in 2020 to constitute 67% of the company's total sales.  A  from Statista added that In , cannabidiol products generated sales of roughly in 2020. By 2025, CBD product sales are predicted to reach nearly in . With estimated sales of , the state of was the country's leading market for CBD products. By 2025, nutraceuticals are forecast to become the largest CBD category in terms of U.S. sales.  Active Companies in the merchant industry include (NASDAQ: OLB), (NASDAQ: GRVI), (NASDAQ: TLRY) (TSX: TLRY), (NASDAQ: CGC) (TSX: WEED), (NASDAQ: CRON) (TSX: CRON).
Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021
- GlobeNewswire - Fri Jul 23, 7:09AM CDT
GlobeNewswire - CMTX
Fri Jul 23, 7:09AM CDT
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") will hold its 2021 Second Quarter Earnings Conference Call on Friday, August 6, 2021 at 8:30 a.m. EDT. Cronos Group's senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 8.84 +1.13% increase
on 07/27/21
Period Open:10.29
Price movement based on the high, low and last over the given period.
10.76 -16.91% decrease
on 07/13/21
-1.35 (-13.12%) decrease
since 07/02/21
3-Month 8.47 +5.55% increase
on 05/11/21
Period Open:9.79
Price movement based on the high, low and last over the given period.
11.37 -21.37% decrease
on 06/09/21
-0.85 (-8.68%) decrease
since 05/04/21
52-Week 6.55 +36.49% increase
on 10/02/20
Period Open:9.42
Price movement based on the high, low and last over the given period.
20.08 -55.48% decrease
on 02/10/21
-0.48 (-5.10%) decrease
since 08/04/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies